The clock is ticking for the Brexit Transition Period coming to an end and we are starting to wonder what are the implications for the Life Sciences sector. This webinar will explore some of the changes that we can expect and aims to answer some of the questions you may have about what next?
What are the implications for the Life Sciences sector from the 1st January? The Transition Period is ending, what next? Where do we from here? How will it effect R&D, exports, imports? What about legacy agreements?
These are some of the questions that this Webinar will answer as we bring together experts to discuss these questions and more.
Bionow's Dave Holmes will provide an Ecosystem update
BIA's Strategic Policy Advisor: Tim Windle will talk about how the Brexit will effect the Life Science Sector
Square One Law Head of Health and Life Sciences Helen Brain will talk about the impact on personal data and potential impace on commercial contracts
Also a panel discussion with Q&A
Attending Bionow online meetings allows attendees to connect directly with one another and put questions / start conversations via the social wall associated with each event even after the event has finished. All delegates have the ability to create new contacts and perhaps link up with old acquaintances through the Bionow event networking portal before, during and after all Bionow online events!